SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-242037
Filing Date
2007-11-09
Accepted
2007-11-09 13:58:36
Documents
8
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 635698
2 MANUFACTURING SERVICES AGREEMENT dex103.htm EX-10.3 124280
3 AMENDMENT OF AGREEMENT, DATED SEPTEMBER 11, 2007 dex104.htm EX-10.4 6221
4 TERMINATION OF AGREEMENT, DATED SEPTEMBER 11, 2007 dex105.htm EX-10.5 6228
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9284
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9287
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3604
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3607
  Complete submission text file 0001193125-07-242037.txt   799627
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 071230249
SIC: 2834 Pharmaceutical Preparations